RxDoctor Payments Data

Donald Setter, DO

Family Medicine · Poulsbo, WANPI 1477715266

Payments from drug & device makers

$229in general payments, 2019–2025

Across 16 payments — averaging $14.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$55
  • Merck$34
  • Amgen$31
  • Boehringer Ingelheim$31
  • Johnson & Johnson$27
  • AstraZeneca$24
  • plus $27 from 2 others

What the payments were for

  • Food & beverage$229100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$229 in reported general payments places this provider in the 65th percentile of 2,275 family medicine providers in Washington.

See all family medicine providers in Washington

Medicare billing

Part B allowed, 2024
$29,346
Medicare patients
98
Services billed
1,441

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin141$65,427
OzempicSemaglutide38$28,116
Spiriva RespimatTiotropium Bromide43$22,945
ArexvyRsvpref3 Antigen/As01e/Pf23$10,938
Stiolto RespimatTiotropium Br/Olodaterol Hcl23$10,228
ShingrixVaricella-Zoster Ge/As01b/Pf33$10,125
Humalog Kwikpen U-100Insulin Lispro16$9,256
Victoza 2-PakLiraglutide14$8,708
PradaxaDabigatran Etexilate Mesylate35$7,697
Liraglutide13$7,156
AlvescoCiclesonide52$6,606
Humulin N KwikpenInsulin Nph Human Isophane34$6,532
Atorvastatin Calcium399$4,718
Humulin NInsulin Nph Human Isophane28$4,415
Wixela InhubFluticasone Propion/Salmeterol14$4,053

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Spiriva Respimat, Stiolto Respimat, Pradaxa$31$106,297242 claims
Novo NordiskOzempic$55$28,11638 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,275 family medicine providers in Washington.

Other family medicine in Poulsbo

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →